Access to Essential Medicines in Primary Health Care Units of South Wollo Zone, Ethiopia

Mohammed Hussien^1*, Fikru Tafese²

¹Department of Public Health, Wollo University, Wollo, Ethiopia.
²Department of Health Service Management, Jimma University, Jimma, Ethiopia.

DOI: 10.4236/oalib.1100983                

Abstract

Background: Lack of access to essential medicines is one of the most important public health problems in Ethiopia. The objective of this study was to verify availability, affordability and prices of essential medicines in primary health care units and private medicine outlets of South Wollo Zone. Methods: A facility-based cross-sectional study was undertaken in 10 primary health care units and 10 private medicine outlets. Data were collected through patient exit interview, record review, observation and interview of relevant bodies. Medicines prices were compared with international reference prices to obtain a median price ratio. The daily wage of the lowest paid government worker had been used to measure medicines affordability. Chi-square test and their p-values at the level of significance of 5% were used to define statistical associations. Odds ratios and their 95% confidence interval were used to look into the strength of association. Results: Average availability of essential medicines in primary health care units and private medicine outlets was 85.5% and 91.1% respectively. Based on prescriptions filled, 94% of the patients left the facility with all the prescribed medicines. The median price ratio of lowest price generics was 0.92, 1.25 and 1.76 times the international reference price for public procurement price, public sector dispensing price and private sector retail price, respectively. Among the total respondents that sought treatment, 56% incurred costs of more than 12.65 Birr on medicines. Conclusion: The survey revealed efficient public procurement price, acceptable retail price and higher availability in both the public and private sectors; however medicines were less affordable in both sectors. Different financing options could improve the affordability of essential medicines for low-income population.

Keywords

Access, Availability, Affordability, Prices, Essential Medicines, South Wollo Zone

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Quick, J.D. (2003) Essential Medicines Twenty-Five Years on: Closing the Access Gap. Health Policy and Planning, 18, 1-3. http://dx.doi.org/10.1093/heapol/18.1.1
[2]	WHO (2004) Equitable Access to Essential Medicines: A Framework for Collective Action. World Health Organization, Geneva.
[3]	Tetteh, E.K. (2008) Provide Affordable Essential Medicines to African Households: The Missing Policies and Institutions for Price Containment. Social Science & Medicine, 66, 569-581. http://dx.doi.org/10.1016/j.socscimed.2007.10.003
[4]	WHO (2004) WHO Medicines Strategy 2004-2007: Countries at the Core. World Health Organization, Geneva.
[5]	DFID (2004) Increasing Access to Essential Medicines in the Developing World: Government of UK Policy and Plans. Department for International Development, London.
[6]	WHO (2004) The World Medicines Situation. World Health Organization, Geneva.
[7]	Cameron, A., Ewen, M., Auton, M. and Abegunde, D. (2011) The World Medicines Situation 2011: Medicines Prices, Availability and Affordability. World Health Organization, Geneva.
[8]	Mendis, S., Fukino, K., Cameron, A., et al. (2007) The Availability and Affordability of Selected Essential Medicines for Chronic Diseases in Six Low- and Middle-Income Countries. Bulletin of the World Health Organization, 85, 279-288. http://dx.doi.org/10.2471/BLT.06.033647
[9]	Cameron, A., Ewen, M., Ross-Degnan, D., Ball, D. and Laing, R. (2009) Medicine Prices, Availability, and Affordability in 36 Developing and Middle-Income Countries: A Secondary Analysis. Lancet, 373, 240-249. http://dx.doi.org/10.1016/S0140-6736(08)61762-6
[10]	FMOH and WHO (2003) Assessment of the Pharmaceutical Sector in Ethiopia. Ministry of Health, Addis Ababa.
[11]	FMOH and WHO (2005) Survey on Prices of Medicines in Ethiopia. Ministry of Health, Addis Ababa.
[12]	Carasso, B.S., Lagarde, M., Tesfaye, A. and Palmer, N. (2009) Availability of Essential Medicines in Ethiopia: An Efficiency-Equity Trade-Off? Tropical Medicine and International Health, 14, 1394-1400. http://dx.doi.org/10.1111/j.1365-3156.2009.02383.x
[13]	FMOH and Health Care Financing Team (2010) Ethiopia’s Fourth National Health Accounts 2007/08. Ministry of Health, Addis Ababa.
[14]	FMOH (2010) Health Sector Development Program IV 2010/11-2014/15. Ministry of Health, Addis Ababa.
[15]	Ryan, P. (2009) Public Sector Healthcare Supply Chain Strategic Network Analysis and Design. The World Bank, Washington DC.
[16]	WHO/HAI (2008) Measuring Medicine Prices, Availability, Affordability and Price Components. World Health Organization and Health Action International, Geneva. http://www.haiweb.org/medicineprices/manual/documents.html
[17]	Gelders, S., Ewen, M., Noguchi, N. and Laing, R. (2006) Price, Availability and Affordability: An International Comparison of Chronic Disease Medicines. World Health Organization, Cairo M.
[18]	MSH (2010) International Drug Price Indicator Guide 2010. Management Sciences for Health, Arlington.
[19]	WHO (2007) WHO Operational Package for Monitoring and Assessing Country Pharmaceutical Situations: Guide for Coordinators and Data Collectors. World Health Organization, Geneva. http://www.who.int/medicines /publications /WHO TCM_2007.2/en/ index.html
[20]	Bogale, T., Haile Mariam, D. and Ali, A. (2005) Costs of Illness and Coping Strategies in a Coffee-Growing Rural District of Ethiopia. Journal of Health, Population and Nutrition, 23, 192-199.
[21]	Russell, S. and Abdella, K. (2002) Too Poor to Be Sick: Coping with the Costs of Illness in East Hararghe, Ethiopia. Save the Children, London.